SHA:600276 Market Cap

SHA:600276 has a market cap or net worth of 342.07 billion as of May 19, 2026. Its market cap has increased by 10.28% in one year.

Market Cap

342.07B

Enterprise Value

302.02B

Revenue

32.56B

Ranking

n/a

PE Ratio

42.26

Stock Price

50.58

Market Cap Chart

Since October 20, 2000, SHA:600276's market cap has increased from 2.58B to 342.07B, an increase of 13,176.17%. That is a compound annual growth rate of 21.05%.

Market Cap History

Date	Market Cap	% Change
May 19, 2026	342.07B	-13.57%
Dec 31, 2025	395.76B	35.60%
Dec 31, 2024	291.86B	1.48%
Dec 29, 2023	287.60B	17.03%
Dec 30, 2022	245.74B	-23.94%
Dec 31, 2021	323.08B	-45.40%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sichuan Biokin Pharmaceutical	106.11B
Zhejiang NHU Company	101.07B
Yunnan Baiyao Group Co.,Ltd	90.82B
Shanghai Fosun Pharmaceutical (Group)	59.14B
Huadong Medicine	54.89B
China Resources Sanjiu Medical & Pharmaceutical	41.49B
Shenzhen Salubris Pharmaceuticals	39.30B
Beijing Tongrentang	37.44B

Market Cap Rankings